The Role of Heat Shock Proteins in Type 1 Diabetes

Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease characterized by recognition of pancreatic β-cell proteins as self-antigens, called autoantigens (AAgs), followed by loss of pancreatic β-cells. (Pre-)proinsulin ([P]PI), glutamic acid decarboxylase (GAD), tyrosine phosphatase IA-2, and t...

Full description

Bibliographic Details
Main Authors: Abu Saleh Md Moin, Manjula Nandakumar, Abdoulaye Diane, Mohammed Dehbi, Alexandra E. Butler
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.612584/full
_version_ 1818723965947871232
author Abu Saleh Md Moin
Manjula Nandakumar
Abdoulaye Diane
Mohammed Dehbi
Alexandra E. Butler
author_facet Abu Saleh Md Moin
Manjula Nandakumar
Abdoulaye Diane
Mohammed Dehbi
Alexandra E. Butler
author_sort Abu Saleh Md Moin
collection DOAJ
description Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease characterized by recognition of pancreatic β-cell proteins as self-antigens, called autoantigens (AAgs), followed by loss of pancreatic β-cells. (Pre-)proinsulin ([P]PI), glutamic acid decarboxylase (GAD), tyrosine phosphatase IA-2, and the zinc transporter ZnT8 are key molecules in T1D pathogenesis and are recognized by autoantibodies detected in routine clinical laboratory assays. However, generation of new autoantigens (neoantigens) from β-cells has also been reported, against which the autoreactive T cells show activity. Heat shock proteins (HSPs) were originally described as “cellular stress responders” for their role as chaperones that regulate the conformation and function of a large number of cellular proteins to protect the body from stress. HSPs participate in key cellular functions under both physiological and stressful conditions, including suppression of protein aggregation, assisting folding and stability of nascent and damaged proteins, translocation of proteins into cellular compartments and targeting irreversibly damaged proteins for degradation. Low HSP expression impacts many pathological conditions associated with diabetes and could play a role in diabetic complications. HSPs have beneficial effects in preventing insulin resistance and hyperglycemia in type 2 diabetes (T2D). HSPs are, however, additionally involved in antigen presentation, presenting immunogenic peptides to class I and class II major histocompatibility molecules; thus, an opportunity exists for HSPs to be employed as modulators of immunologic responses in T1D and other autoimmune disorders. In this review, we discuss the multifaceted roles of HSPs in the pathogenesis of T1D and in autoantigen-specific immune protection against T1D development.
first_indexed 2024-12-17T21:18:54Z
format Article
id doaj.art-e5f1d9f275f74aa1944559f9db084e57
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-17T21:18:54Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e5f1d9f275f74aa1944559f9db084e572022-12-21T21:32:16ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-01-011110.3389/fimmu.2020.612584612584The Role of Heat Shock Proteins in Type 1 DiabetesAbu Saleh Md MoinManjula NandakumarAbdoulaye DianeMohammed DehbiAlexandra E. ButlerType 1 diabetes (T1D) is a T-cell mediated autoimmune disease characterized by recognition of pancreatic β-cell proteins as self-antigens, called autoantigens (AAgs), followed by loss of pancreatic β-cells. (Pre-)proinsulin ([P]PI), glutamic acid decarboxylase (GAD), tyrosine phosphatase IA-2, and the zinc transporter ZnT8 are key molecules in T1D pathogenesis and are recognized by autoantibodies detected in routine clinical laboratory assays. However, generation of new autoantigens (neoantigens) from β-cells has also been reported, against which the autoreactive T cells show activity. Heat shock proteins (HSPs) were originally described as “cellular stress responders” for their role as chaperones that regulate the conformation and function of a large number of cellular proteins to protect the body from stress. HSPs participate in key cellular functions under both physiological and stressful conditions, including suppression of protein aggregation, assisting folding and stability of nascent and damaged proteins, translocation of proteins into cellular compartments and targeting irreversibly damaged proteins for degradation. Low HSP expression impacts many pathological conditions associated with diabetes and could play a role in diabetic complications. HSPs have beneficial effects in preventing insulin resistance and hyperglycemia in type 2 diabetes (T2D). HSPs are, however, additionally involved in antigen presentation, presenting immunogenic peptides to class I and class II major histocompatibility molecules; thus, an opportunity exists for HSPs to be employed as modulators of immunologic responses in T1D and other autoimmune disorders. In this review, we discuss the multifaceted roles of HSPs in the pathogenesis of T1D and in autoantigen-specific immune protection against T1D development.https://www.frontiersin.org/articles/10.3389/fimmu.2020.612584/fulltype 1 diabetesheat shock proteinstype 1 diabetes pathogenesisautoantigensmetabolic stressantigen specific immunotherapy
spellingShingle Abu Saleh Md Moin
Manjula Nandakumar
Abdoulaye Diane
Mohammed Dehbi
Alexandra E. Butler
The Role of Heat Shock Proteins in Type 1 Diabetes
Frontiers in Immunology
type 1 diabetes
heat shock proteins
type 1 diabetes pathogenesis
autoantigens
metabolic stress
antigen specific immunotherapy
title The Role of Heat Shock Proteins in Type 1 Diabetes
title_full The Role of Heat Shock Proteins in Type 1 Diabetes
title_fullStr The Role of Heat Shock Proteins in Type 1 Diabetes
title_full_unstemmed The Role of Heat Shock Proteins in Type 1 Diabetes
title_short The Role of Heat Shock Proteins in Type 1 Diabetes
title_sort role of heat shock proteins in type 1 diabetes
topic type 1 diabetes
heat shock proteins
type 1 diabetes pathogenesis
autoantigens
metabolic stress
antigen specific immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.612584/full
work_keys_str_mv AT abusalehmdmoin theroleofheatshockproteinsintype1diabetes
AT manjulanandakumar theroleofheatshockproteinsintype1diabetes
AT abdoulayediane theroleofheatshockproteinsintype1diabetes
AT mohammeddehbi theroleofheatshockproteinsintype1diabetes
AT alexandraebutler theroleofheatshockproteinsintype1diabetes
AT abusalehmdmoin roleofheatshockproteinsintype1diabetes
AT manjulanandakumar roleofheatshockproteinsintype1diabetes
AT abdoulayediane roleofheatshockproteinsintype1diabetes
AT mohammeddehbi roleofheatshockproteinsintype1diabetes
AT alexandraebutler roleofheatshockproteinsintype1diabetes